- Video Center
- Social Media
- Media Contacts
Monheim, June 17, 2020 – To assist smallholder farmers in Asia, Africa and Latin America who are facing additional challenges resulting from COVID-19, Bayer, as part of its societal engagement activities and through its new “Better Farms, Better Lives” initiative, is providing seeds and crop protection inputs as well as assistance with market access and support for health and safety needs.
“Better Farms, Better Lives” is in line with Bayer’s overall aspiration to help build a world where there is Health for All, Hunger for None. The initiative focuses on providing smallholder farmers with the assistance needed to address the additional challenges they may be facing as a result of the coronavirus pandemic.
“Smallholder farmers are essential to providing food security to billions of people, but the on-going COVID pandemic is placing extra challenges on their ability to produce food for their communities and beyond,” said Liam Condon, President of Bayer’s Crop Science Division. “In this critical time, our hope is that our Better Farms, Better Lives initiative, additional support and partnerships with local and global NGOs will not only result in resiliency for smallholders but will also ensure this current health and economic crisis does not turn into a hunger crisis.”
The COVID pandemic has caused logistical issues for many farmers globally due to enforced lockdowns which has limited access to seeds, crop protection inputs and labor. As a result of disruptions to food supplies, consumers may ultimately see higher food prices, ironically at a time when many farmers are seeing reduced incomes due to disruptions in the supply chain and the subsequent lack of market access.
Bayer is committed to helping more than 100 million smallholders in low- and middle-income countries by 2030. The immediate COVID-19 response through the “Better Farms, Better Lives” initiative complements on-going smallholder support which will aid in mid-term recovery as well as long-term resilience. Additionally, in collaboration with others and to ensure the greatest successful impact for smallholders, Bayer will work and expand its partnerships with governments, internationally recognized NGOs and local organizations; create a Smallholder Center of Excellence for sharing successes; provide accelerated access to digital farming tools to increase capabilities; scale up existing and new value chain partnerships and further expand value chain partnerships across Asia-Pacific countries.
Through this initiative, Bayer plans to help up to two million smallholder farmers, that provide food security to tens of millions of families in vulnerable communities. The Better Life Farming Care Packages will be tailored to specific local needs and may include seeds for crops such as tomatoes, peppers, rice and corn to sustain livelihoods, crop protection products, personal protective equipment and safety and training materials.
Of the estimated, 550 million smallholder farmers worldwide, it’s estimated that 97 percent work on farms that are smaller than 10 hectares or 25 acres and produce more than 80 percent of the food in developing countries. These farms are often family-run businesses that have a long history in the communities where they live.
For more information on Bayer’s “Better Lives, Better Farms” initiative and its commitment to smallholder farmers, visit www.bayer.com.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros. For more information, go to www.bayer.com.
Find more information at www.bayer.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.